CTOs on the Move

Zenflow

www.zenflow.com

 
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign prostatic hyperplasia (BPH). Millions of patients do not see effective relief from drugs, yet decline to undergo an invasive surgical procedure with high risk of side effects such as sexual dysfunction.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.zenflow.com
  • 395 Oyster Point Blvd Suite 501
    South San Francisco, CA USA 94080
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Zenflow raised $24.3M on 04/15/2021

Similar Companies

Instrumentation Laboratory

Instrumentation Laboratory is a Lexington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NeoSync

NeoSync is a clinical-stage company with a proprietary platform technology being used to develop advanced, non-invasive neuromodulation products.

Axelgaard Manufacturing Co

Founded in 1985, Axelgaard Manufacturing Co., Ltd. (AMC) has grown to become the premier manufacturer of neurostimulation electrodes. Our primary brand is our patented PALS Neurostimulation Electrodes. We are dedicated to providing the highest quality

Fortec Medical

The ForTec Laser Rental Program provides medical lasers to hospitals, surgical centers and physicians delivering the latest in therapies and treatments.

Cvrx

CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™ is designed to trigger the body`s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology. Barostim neo is CE marked in Europe for the treatment of hypertension patients. It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.